StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > We do not offer Aristotle.

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Dec 12, 2024 4:11pm

29 Views

Post# 36359795

RE:RE:RE:We do not offer Aristotle.

Give me some numbers as to how many referrals stagezero gives to care. Would it be a number close to zero?

Your forte seems to be insulting those you disagree with, a sign of frustration.

Mykndrsn wrote: Patients are referred to Care after a positive test. Duh. The other two simps who comment here are clueless and useless. Best ignored.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?